» Articles » PMID: 12498425

Epidemiology and Prevention of Ovarian Hyperstimulation Syndrome (OHSS): a Review

Overview
Date 2002 Dec 25
PMID 12498425
Citations 154
Authors
Affiliations
Soon will be listed here.
Abstract

Ovarian hyperstimulation syndrome (OHSS) is a rare iatrogenic complication of ovarian stimulation occurring during the luteal phase or during early pregnancy. Fortunately, the reported prevalence of the severe form of OHSS is small, ranging from 0.5 to 5%. Nevertheless, as this is an iatrogenic complication of a non-vital treatment with a potentially fatal outcome, the syndrome remains a serious problem for specialists dealing with infertility. The aim of this literature review was to determine whether it is possible to identify patients at risk, and which preventive method should be applied when an exaggerated ovarian response occurs. Data pertaining to the epidemiology and prevention of OHSS in women were searched using Medline, Current Contents and PubMed, and are summarized. Preventive strategies attempt either to limit the dose or concentration of hCG or to find a way to induce luteolysis without inducing a detrimental effect on endometrial and oocyte quality. The following particular preventive strategies were reviewed: cancelling the cycle; coasting; early unilateral ovarian follicular aspiration (EUFA); modifying the methods of ovulation triggering; administration of glucocorticoids, macromolecules and progesterone; cryopreservation of all embryos; and electrocautery or laser vaporization of one or both ovaries.

Citing Articles

New Insights on In Vitro Maturation of Oocytes for Fertility Preservation.

Gotschel F, Sonigo C, Becquart C, Sellami I, Mayeur A, Grynberg M Int J Mol Sci. 2024; 25(19).

PMID: 39408934 PMC: 11477201. DOI: 10.3390/ijms251910605.


Ovarian Hyperstimulation Syndrome (OHSS): A Narrative Review and Legal Implications.

Gullo G, Cucinella G, Stojanovic V, Stojkovic M, Bruno C, Streva A J Pers Med. 2024; 14(9).

PMID: 39338169 PMC: 11433561. DOI: 10.3390/jpm14090915.


[The best evidence for the management of ovarian hyper-stimulation syndrome in patients undergoing assisted reproductive therapy].

He Y, Wang Z, Zhang Y, Jiang X, Shen X, Xu M Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024; 53(5):632-640.

PMID: 39319473 PMC: 11528148. DOI: 10.3724/zdxbyxb-2024-0349.


Severe ovarian hyperstimulation syndrome following sole gonadotropin-releasing hormone (GnRH) agonist trigger: a case series and literature review.

Berkovitz-Shperling R, Samara N, Meir R, Dominsky O, Azam F, Feferkorn I Arch Gynecol Obstet. 2024; 310(5):2297-2304.

PMID: 39302412 PMC: 11485447. DOI: 10.1007/s00404-024-07740-7.


Association of HOMA-IR with unexpected poor ovarian response in non-obese women in poseidon 1: a retrospective cohort study.

Li Y, Zhang S, Zhang C J Ovarian Res. 2024; 17(1):174.

PMID: 39198856 PMC: 11351649. DOI: 10.1186/s13048-024-01491-4.